Peritoneal Carcinomatosis: Clinical Trials

121 trials for Peritoneal Carcinomatosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

48 completed, 26 recruiting, 19 unknown, 12 terminated. 48 Phase 2, 29 Phase 1, 26 Not applicable, 6 Phase 3, 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 248Completed 17, Recruiting 9, Terminated 7, Unknown 6, Active not recruiting 4, Not yet recruiting 2, Suspended 2, Withdrawn 1
Phase 129Completed 12, Recruiting 5, Active not recruiting 4, Unknown 4, Terminated 3, Withdrawn 1
Not applicable26Completed 11, Recruiting 7, Unknown 4, Terminated 2, Active not recruiting 1, Suspended 1
Phase 36Active not recruiting 2, Unknown 2, Recruiting 1, Terminated 1
Early Phase 12Recruiting 1, Unknown 1
Phase 41Recruiting 1

Follow Peritoneal Carcinomatosis: new trials by email Literature Review of Peritoneal Carcinomatosis trials Research Report on Peritoneal Carcinomatosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Paricalcitol Versus Pirfenidone for Improving Surgical Resectability in Patients With Peritoneal Cancer
Paricalcitol, pirfenidone - Peritoneal (Metastatic) Cancer, Peritoneal Carcinoma
Phase 2Not yet recruitingPatrick Wagner, MD, FACS742026-09-012026-10-05
Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
Mitomycin C (MMC), Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) - Peritoneal Carcinomatosis
Phase 1RecruitingH. Lee Moffitt Cancer Center and Research Institute242026-08-052026-09-16
MRI-Guided Adaptive Radiotherapy for Limited Peritoneal Metastases (MARACAS Trial).
MRI-guided stereotactic body radiotherapy - Peritoneal Carcinomatosis, Oligometastatic Disease
Phase 2Not yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS342026-07-012026-05-18
Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)
Modified early post-operative intraperitoneal chemotherapy (mEPIC) - Peritoneal Carcinomatosis, Appendiceal Neoplasms
Phase 2RecruitingCiusss de L'Est de l'Île de Montréal252026-05-012026-05-14
Heated Versus Aerosol-based Laparoscopic Chemotherapy for Cancer That Has Spread to the Peritoneum (Abdominal Lining)
Heated intra-peritoneal chemotherapy, Aerosolized intra-peritoneal chemotherapy - Peritoneal (Metastatic) Cancer, Peritoneal Carcinomatosis
Phase 2RecruitingPatrick Wagner, MD, FACS2002026-01-052026-02-27
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Standard of Care Chemotherapy, Biospecimen Collection, Computed Tomography - Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Phase 2 / Phase 3RecruitingECOG-ACRIN Cancer Research Group1482025-10-242026-10-05
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
Cisplatin, Mitomycin - Gastric Cancer, Peritoneal Carcinomatosis
Phase 2RecruitingUniversity of Chicago212025-09-092026-09-08
Blood Clearance Kinetics of the Nucleosome and CTCF in Peritoneal Metastasis Colorectal Cancer.
Blood sampling - Peritoneal Carcinomatosis, Peritoneal Metastases From Colorectal Cancer
Not applicableRecruitingHospices Civils de Lyon582025-05-062026-02-13
Intensification Treatment of Ovarian Cancer by PIPAC
PIPAC - Advanced Epithelial Ovarian Cancer, Peritoneal Carcinomatosis
Phase 2RecruitingMoscow Regional Oncological Dispensary1602025-04-022026-04-07
Enhanced Recovery After Surgery (ERAS) in Patients With Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
ERAS Perioperative Management Protocol - Peritoneal Carcinomatosis
Not applicableRecruitingFondazione del Piemonte per l'Oncologia3002025-01-232026-04-03
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
Pafolacianine (CYTALUX) with intraoperative fluorescent near-infrared (NIR) imaging - Gastrointestinal Cancer, Peritoneal Carcinomatosis
Early Phase 1RecruitingUniversity of California, Irvine102024-11-132026-02-27
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer or Malignant Peritoneal Mesothelioma
M28z1XXPD1DNR CAR - Mesothelin Positive, Mesothelin-Expressing Tumors
Phase 1RecruitingMemorial Sloan Kettering Cancer Center322024-09-302026-10-15
Molecular Citology to Detect Free Cancer Cells in Peritoneal Fluid
Peritoneal Carcinomatosis
CompletedUniversity of Campania Luigi Vanvitelli1082024-07-012026-03-20
A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
Radspherin - Peritoneal Carcinomatosis, Ovarian Cancer
Phase 2RecruitingOncoinvent Solutions AS1142024-06-152026-05-20
The PIPAC-OPC7 Study: The Use of PET/CT Scans as a Method of Evaluation in Patients Treated With PIPAC, a Pilot Study.
scan - Peritoneal Cancer, Peritoneal Metastases
CompletedOdense University Hospital342024-03-152026-03-16
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) and Electrostatic PIPAC (ePIPAC) With Paclitaxel In Patients With Peritoneal Carcinomatosis
Paclitaxel - Peritoneal Carcinomatosis
Phase 1UnknownNational University Hospital, Singapore362023-08-042024-05-29
Galunisertib Combined With Capecitabine in Advanced CRC With PM
Galunisertib plus capecitabine - Colorectal Cancer Metastatic, Peritoneal Carcinomatosis
Phase 1 / Phase 2Active not recruitingThe Netherlands Cancer Institute312023-07-282026-07-13
Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis
FAPI PET/CT - Cancer, Peritoneal Carcinomatosis
Not applicableRecruitingJules Bordet Institute802023-05-302025-03-31
Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis
Biospecimen Collection (Blood, Ascites/Peritoneal Wash Fluid and/or Tumor Samples) - Peritoneal Carcinomatosis, Gastrointestinal Peritoneal Carcinomatosis
Not applicableRecruitingUniversity of California, Irvine202023-05-042026-08-14
Near-infrared Imaging With Indocyanine Green for Detection of Peritoneal Metastases for Gastric Adenocarcinoma.
Indocyanine green - Gastric Cancer, Gastric Adenocarcinoma
Phase 2TerminatedLaval University112022-12-152024-04-02

Showing 20 of 121. Sign in to see all of them.

Narrower conditions

Peritoneal Neoplasms (121)  ·  Stomach Neoplasms (30)  ·  Colorectal Neoplasms (24)  ·  Ovarian Neoplasms (19)  ·  Appendiceal Neoplasms (11)  ·  Neoplasms (11)  ·  Colonic Neoplasms (10)  ·  Pancreatic Neoplasms (7)  ·  Carcinoma (6)  ·  Fallopian Tube Neoplasms (6)  ·  Pseudomyxoma Peritonei (6)  ·  Breast Neoplasms (5)  ·  Gastrointestinal Neoplasms (4)  ·  Neoplasm Metastasis (4)  ·  Carcinoma, Ovarian Epithelial (3)

Broader conditions

Abdominal Neoplasms (121)  ·  Digestive System Diseases (121)  ·  Neoplasms by Site (121)  ·  Digestive System Neoplasms (120)  ·  Peritoneal Diseases (120)  ·  Neoplasms (110)  ·  Gastrointestinal Diseases (56)  ·  Gastrointestinal Neoplasms (52)  ·  Intestinal Diseases (31)  ·  Colonic Diseases (30)  ·  Intestinal Neoplasms (30)  ·  Stomach Diseases (30)  ·  Endocrine System Diseases (28)  ·  Endocrine Gland Neoplasms (27)  ·  Rectal Diseases (24)

Interventions

Hyperthermic Intraperitoneal Chemotherapy (15)  ·  Cisplatin (13)  ·  Oxaliplatin (10)  ·  Cytoreduction Surgical Procedures (9)  ·  Paclitaxel (9)  ·  Fluorouracil (7)  ·  Mitomycin (7)  ·  Doxorubicin (6)  ·  Leucovorin (4)  ·  Blood Specimen Collection (3)  ·  Docetaxel (3)  ·  Laparoscopy (3)  ·  sodium thiosulfate (3)  ·  1,2-diaminocyclohexaneplatinum II citrate (2)  ·  Capecitabine (2)

Sponsors

National Cancer Institute (NCI) (6)  ·  Hospices Civils de Lyon (4)  ·  University Hospital, Ghent (4)  ·  Institut du Cancer de Montpellier - Val d'Aurelle (3)  ·  Jules Bordet Institute (3)  ·  Laval University (3)  ·  M.D. Anderson Cancer Center (3)  ·  The Netherlands Cancer Institute (3)  ·  University of California, Irvine (3)  ·  CHU de Reims (2)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (2)  ·  Fondazione del Piemonte per l'Oncologia (2)  ·  Koen Rovers (2)  ·  Maimónides Biomedical Research Institute of Córdoba (2)  ·  Michael Bau Mortensen (2)

Countries

United States (32)  ·  Belgium (13)  ·  France (13)  ·  Germany (9)  ·  Netherlands (8)  ·  China (7)  ·  Italy (7)  ·  Canada (6)  ·  Spain (6)  ·  Denmark (4)  ·  Norway (2)  ·  Russia (2)  ·  Singapore (2)  ·  South Korea (2)  ·  Sweden (2)

Top investigators

Alexandre Brind'Amour, MD (3)  ·  Andrew M Blakely, M.D. (2)  ·  Brian D Badgwell (2)  ·  Gabriel Liberale, MD (2)  ·  Maheswari Senthil, MD (2)  ·  Patrick Wagner, MD (2)  ·  Wim P Ceelen, MD, PhD, Prof (2)  ·  Agnieszka Michael (1)  ·  Alexander Zakharenko, PhD (1)  ·  Alexandra R Brandt-Kerkhof, MD (1)  ·  Alexey S. Dzasokhov, MD, PhD (1)  ·  Alvaro Arjona-Sanchez, PhD (1)  ·  Amir A Jazaeri (1)  ·  Andre Roncon Dias, MD, PhD (1)

Results publications

PMID 20500867, PMID 20525328, PMID 23377563, PMID 23765417, PMID 24006094, PMID 24275155, PMID 24447964, PMID 26681640, PMID 27520560, PMID 29149865, PMID 29773661, PMID 29899763, PMID 30131226, PMID 30463745, PMID 30607301, PMID 30755498, PMID 30911655, PMID 30911663, PMID 31023318, PMID 31060544, PMID 31084544, PMID 31352425, PMID 31469058, PMID 32556731, PMID 32572849, PMID 32594200, PMID 32738543, PMID 33528867, PMID 33544279, PMID 33902498, PMID 34009291, PMID 34070561, PMID 34757489, PMID 35549912, PMID 35551444, PMID 35843174, PMID 36410913, PMID 36513815, PMID 36604127, PMID 36795510, PMID 36870941, PMID 37124504, PMID 37227734, PMID 37460370, PMID 37580610, PMID 37875869, PMID 37916797, PMID 37993560, PMID 38471508, PMID 39288528

NIH funding

2009 (2), 2016 (2), 2018 (2), 2019 (2), 2015 (1), 2017 (1), P01CA132714 (1), P30CA006973 (1), P30CA033572 (1), P30CA072720 (1), R21CA135005 (1), U01CA070095 (1), U01CA132123 (1), U10CA180820 (1), UM1CA186644 (1)